Differential effects on current kinetics by point mutations in the lurcher motif of NR1/NR2A receptors

Journal of Pharmacology and Experimental Therapeutics

Volumn 312, Issue 3, 2005, Pages 899-904

  Hu, Bo ^a   Zheng, Fang ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

N METHYL DEXTRO ASPARTIC ACID RECEPTOR 1; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2A; ZINC;

ARTICLE; CELL STRAIN HEK293; CHANNEL GATING; CONTROLLED STUDY; ELECTRIC CURRENT; HUMAN; HUMAN CELL; ION TRANSPORT; MUTATIONAL ANALYSIS; POINT MUTATION; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN MOTIF; PROTON TRANSPORT;

AMINO ACID MOTIFS; AMINO ACID SEQUENCE; CELL LINE; HUMANS; ION CHANNEL GATING; KINETICS; MOLECULAR SEQUENCE DATA; POINT MUTATION; RECEPTORS, N-METHYL-D-ASPARTATE; ZINC;

EID: 14344252254     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.104.077388     Document Type: Article

References (29)

1. Armstrong N, Sun Y, Chen GQ, and Gouaux E (1998) Structure of a glutamate receptor ligand binding core in complex with kainate. Nature (Lond) 395:913-917.
2. Banke T, Dravid SM, and Traynelis SF (2005) Protons trap NR1/NR2B receptors in a non-conducting state. J Neurosci (in press).
3. Beck C, Wollmuth LP, Seeburg PH, Sakmann B, and Kuner T (1999) NMDAR channel segments forming the extracellular vestibule inferred from the accessibility of substituted cysteines. Neuron 22:559-570.
4. Chen C and Okayama H (1987) High-efficiency transformation of mammalian cells by plasmid DNA. Mol Cell Biol 7:2745-2752.
5. Choi Y-B and Lipton SA (1999) Identification and mechanism of action of two histidine residues underlying high affinity zinc inhibition of NMDA receptors. Neuron 23:171-180.
6. Colquhoun D (1998) Binding, gating, affinity and efficacy: the interpretation of structure-activity relationships for agonists and of the effects of mutating receptors. Br J Pharmacol 125:924-947.
7. Dingledine R, Borges K, Sowie D, and Traynelis SF (1999) The glutamate receptor ion channels. Pharmacol Rev 51:7-61.
8. Dirnagl U, Iadecola C, and Moskowitz MA (1999) Pathobiology of ischemic stroke: an integrated view. Trends Neurosci 22:391-397.
9. Furukawa H and Gouaux E (2003) Mechanisms of activation, inhibition and specificity: crystal structure of the NMDA receptor NR1 ligand-binding core. EMBO (Eur Mol Biol Organ) J 22:2873-2885.
10. Jones KS, Van Dongen HMA, and Van Dongen AMJ (2002) The NMDA receptor M3 segment is a conserved transduction element coupling ligand binding to channel opening. J Neurosci 22:2044-2053.
11. Kohda K, Wang Y, and Yuzaki M (2000) Mutation of a glutamate receptor motif reveals its role in gating and delta2 receptor channel properties. Nat Neurosci 3:315-322.
12. Lee J-M, Zipfel G-J, and Choi DW (1999) The changing landscape of ischaemic brain injury mechanisms. Nature (Lond) 399:A7-A14.
13. Lester RA and Jahr CE (1992) NMDA channel behavior depends on agonist affinity. J Neurosci 12:635-643.
14. Low C-M, Lyuboslavsky P, French A, Lee P, Wyatte K, Thiel WH, Marchan E, Igarashi K, Kashiwagi K, Gernert K, et al. (2003) Molecular determinants of proton sensitive NMDA receptor gating. Mol Pharmacol 63:1212-1222.
15. Low C-M, Zheng F, Lyuboslavsky P, and Traynelis SF (2000) Molecular determinants of coordinated proton and zinc inhibition of NMDA NR1/NR2A receptors. Proc Natl Acad Sci USA 97:11062-11067.
16. Meldrum BS, Akbar MT, and Chapman AG (1999) Glutamate receptors and transporters in genetic and acquired models of epilepsy. Epilepsy Res 36:189-204.
17. Mott DD, Doherty JJ, Zhang S, Washburn MS, Fendley MJ, Lyuboslavsky P, Traynelis SF, and Dingledine R (1998) Phenylethanolamines inhibit NMDA receptors by enhancement of proton inhibition. Nat Neurosci 1:659-667.
18. Obrenovitch TP and Urenjak J (1997) Is high extracellular glutamate the key to excitotoxicity in traumatic brain injury. J Neurotrauma 14:677-698.
19. Olney JW, Wozniak DF, and Farber NB (1997) Excitotoxic neurodegeneration in Alzheimer disease: new hypothesis and new therapeutic strategies. Arch Neurol 54:1234-1240.
20. Olney JW, Wozniak DF, Jevtovic-Todorovic V, and Ikonomidou C (2001) Glutamate signaling and the fetal alcohol syndrome. Ment Retard Dev Disabil Res Rev 7:267-275.
21. Paoletti P, Ascher P, and Neyton J (1997) High affinity zinc inhibition of NMDA NR1-NR2A receptors. J Neurosci 17:5711-5725.
22. Park AJ and Williams K (1997) Influence of extracellular pH on inhibition by ifenprodil at N-methyl-D-aspartate receptors in Xenopus oocytes. Neurosci Lett 225:29-32.
23. + channels by intracellular pH. Eur J Biochem 267:5837-5841.
24. Sobolevsky AI, Beck C, and Wollmuth LP (2002a) Molecular rearrangements of the extracellular vestibule in NMDAR channels during gating. Neuron 33:75-85.
25. Sobolevsky AI, Rooney L, and Wollmuth LP (2002b) Staggering of subunits in NMDAR channels. Biophys J 83:3304-3314.
26. Taverna F, Xiong Z-G, Brandes L, Roder JC, Salter MW, and MacDonald JF (2000) The lurcher mutation of an α-amino-3-hydroxy-5-methyl-4- isoxazolepropionic acid receptor subunit enhances potency of glutamate and converts an antagonist to an agonist. J Biol Chem 275:8475-8479.
27. Traynelis SF, Hartley M, and Heinemann SF (1995) Control of proton sensitivity of the NMDA receptor by RNA splicing and polyamines. Science (Wash DC) 268:873-876.
28. 2 and pH. J Gen Physiol 116:33-45.
29. Zheng F, Erreger K, Low C-M, Banke T, Lee CJ, Conn PJ, and Traynelis SF (2001) Allosteric interaction between the amino terminal domain and the ligand binding domain of NR2A. Nature Neurosci 4:894-901.